Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › IN › Elkhart › NPI 1013912286
Clinic

Privia Medical Group Indiana, LLC

Privia Medical Group Indiana, LLC was paid $2.57M by Medicaid between Jan 2018 and Dec 2024, across 110 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 62% of everything it billed.

33Billing provider infoPRIVIA MEDICAL GROUP INDIANA, LLC
ELKHART, IN 46514
33aNPI1013912286assigned 06/15/2005
33bProvider typeMulti-Specialty Clinic/Center
28Total paid$2.57M
24GClaims187,527
24DCodes billed110
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Multi-Specialty Clinic/Center providers in Indiana

Rank by total paid#4 of 16
Median peer was paid$295K
This provider vs. median8.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$25K$50K$75K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201827,191$126K
201926,093$285K
202021,471$309K
202122,347$426K
202223,374$449K
202332,305$430K
2024incomplete34,746$543K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 62% 41,036 35,206 $1.60M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 16% 12,939 11,078 $403K
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity 2.3% 1,260 1,114 $59K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 2.1% 1,571 805 $54K
36415 Collection of venous blood by venipuncture 1.8% 25,824 22,055 $46K
80053 Comprehensive metabolic panel 1.5% 9,108 7,709 $38K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.3% 13,178 10,979 $34K
84443 Thyroid stimulating hormone (TSH) 1.1% 3,782 3,418 $29K
84481 1.1% 2,951 2,679 $28K
99215 Doctor's office visit, returning patient (complex)Prolong outpt/office vis <1% 430 402 $22K
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity <1% 495 443 $20K
84439 <1% 4,099 3,725 $19K
98 more codes
83036 Hemoglobin; glycosylated (A1C) <1% 4,664 $18K
J0585 Injection, onabotulinumtoxina, 1 unit <1% 31 $18K
80048 Basic metabolic panel (calcium, ionized) <1% 6,257 $16K
95251 <1% 1,014 $14K
95816 <1% 170 $9K
99205 Prolong outpt/office vis <1% 74 $7K
96367 <1% 433 $7K
99307 <1% 869 $7K
80061 Lipid panel <1% 1,411 $7K
99308 Subsequent nursing facility care, per day, straightforward <1% 737 $6K
83721 <1% 2,551 $6K
97803 <1% 166 $5K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 99 $5K
99222 Initial hospital care, per day, moderate complexity <1% 89 $5K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 859 $5K
82728 <1% 719 $5K
86140 <1% 1,675 $4K
83718 <1% 2,415 $4K
11721 <1% 455 $4K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 171 $4K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 131 $4K
85651 <1% 1,974 $4K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 77 $3K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 217 $3K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 204 $3K
84478 <1% 2,338 $3K
99305 <1% 104 $2K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 164 $2K
90682 <1% 151 $2K
J2469 Injection, palonosetron hcl, 25 mcg <1% 53 $2K
95819 <1% 12 $2K
51798 <1% 467 $2K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 90 $2K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 319 $1K
80050 General health panel <1% 211 $1K
20610 <1% 129 $1K
90686 <1% 170 $1K
95117 <1% 256 $1K
84075 <1% 1,784 $953.81
96375 Therapeutic injection; each additional sequential IV push <1% 103 $952.52
80305 <1% 252 $921.04
84450 <1% 2,002 $915.79
96417 <1% 28 $841.75
99232 Hospital visit by a doctor, follow-up day <1% 21 $809.30
84460 <1% 2,007 $679.87
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient <1% 15 $672.33
92015 Determination of refractive state <1% 96 $668.27
82040 <1% 1,993 $653.06
84466 <1% 134 $647.48
90750 <1% 47 $577.09
0011A <1% 51 $483.73
84155 <1% 2,007 $475.97
82570 <1% 211 $473.16
82043 <1% 162 $445.73
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 125 $431.19
0012A <1% 42 $409.31
92557 <1% 30 $406.69
83540 <1% 134 $339.63
87428 <1% 12 $309.40
0064A <1% 94 $297.68
90662 <1% 249 $290.51
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 81 $286.14
90732 <1% 13 $266.94
0004A <1% 22 $260.47
99406 <1% 16 $232.13
87420 <1% 22 $211.50
0134A <1% 33 $184.50
3044F <1% 517 $180.00
81001 <1% 384 $174.30
96127 <1% 67 $174.15
83735 <1% 197 $163.14
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 148 $135.96
J1030 Injection, methylprednisolone acetate, 40 mg <1% 34 $107.35
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) <1% 3,358 $74.36
86200 <1% 45 $64.14
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 93 $57.03
J7050 Infusion, normal saline solution, 250 cc <1% 1,094 $45.91
82607 <1% 26 $45.82
81002 <1% 27 $41.76
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 14 $41.37
86431 <1% 59 $40.12
85610 <1% 117 $28.64
81003 <1% 13 $18.88
3078F 0% 7,489 $0.00
G0444 Annual depression screening, 5 to 15 minutes 0% 222 $0.00
3077F 0% 367 $0.00
71046 Radiologic examination, chest; 2 views 0% 12 $0.00
84550 0% 14 $0.00
99497 0% 45 $0.00
3074F 0% 7,873 $0.00
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit 0% 304 $0.00
3080F 0% 156 $0.00
G0008 Administration of influenza virus vaccine 0% 562 $0.00
3079F 0% 2,409 $0.00
3075F 0% 1,294 $0.00
99070 0% 91 $0.00
G0442 Annual alcohol misuse screening, 5 to 15 minutes 0% 97 $0.00
G0009 Administration of pneumococcal vaccine 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialVANDERGRIFT, THOMAS (CHIEF EXECUTIVE ADMINISTRATOR)